Get the Stockscreener App
0.1102
0.27%
0.0003
Cellyan Biotechnology Co Ltd stock is traded at $0.1102, with a volume of 246.87K.
It is up +0.27% in the last 24 hours and down -7.32% over the past month.
Cellyan Biotechnology Co Ltd formerly, Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
See More
Previous Close:
$0.1099
Open:
$0.112
24h Volume:
246.87K
Relative Volume:
0.44
Market Cap:
$5.43M
Revenue:
Net Income/Loss:
P/E Ratio:
-
EPS:
-
Net Cash Flow:
1W Performance:
-1.61%
1M Performance:
-7.32%
6M Performance:
-84.26%
1Y Performance:
-90.82%
1-Day Range:
$0.1005
$0.112
1-Week Range:
$0.0962
$0.1136
52-Week Range:
$0.095
$1.7194
Cellyan Biotechnology Co Ltd Stock (HKPD) Company Profile
Name
Cellyan Biotechnology Co Ltd
Sector
Industry
Phone
-
Address
-
Compare HKPD vs MCK, COR, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HKPD
Cellyan Biotechnology Co Ltd
|
0.1102 | 5.43M | 0 | 0 | 0 | 0.00 |
MCK
Mckesson Corp
|
1,004.84 | 117.15B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
340.92 | 65.06B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
254.06 | 58.83B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
86.38 | 9.63B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.35 | 1.16B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cellyan Biotechnology Co Ltd Stock (HKPD) Latest News
Cellyan Biotechnology Shareholders Approve 1-for-20 Consolidation and Charter Overhaul - The Globe and Mail
Cellyan Biotechnology Shareholders Approve 1-for-20 Consolidation and Charter Overhaul - TipRanks
Cellyan Biotechnology (NASDAQ: HKPD) Announces Extraordinary Meeting on September 21, 2026 for Share Consolidation Proposal - Kalkine Media
12 Industrials Stocks Moving In Thursday's Pre-Market Session - benzinga.com
Cellyan Biotechnology Calls September 21 EGM to Approve 1-for-20 Share Consolidation - TipRanks
Microcaps GPRO, FLYE, HKPD, VIVS to Watch Now - marketscreener.com
12 Industrials Stocks Moving In Wednesday's Pre-Market Session - benzinga.com
12 Industrials Stocks Moving In Tuesday's After-Market Session - benzinga.com
Microcaps GPRO, FLYE, HKPD, VIVS to Watch Now - FinancialContent
12 Industrials Stocks Moving In Tuesday's Intraday Session - benzinga.com
JYD Stock Price, Quote & News - Syfe
Click Files up to $100 Million Mixed Shelf - Yahoo Finance
Cellyan Biotechnology (HKPD) Advances 3.61% as Shares Approach Key $0.44 ResistanceMA Cross Alert - vinanet.vn
Zhengye Biotechnology Holding Limited Regains Compliance with Nasdaq Bid Price Requirement - Yahoo Finance
SunCar Technology Group Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Compliance Deficiency - Yahoo Finance
Kam Leung Chan Net Worth (2026) - GuruFocus
These stocks have an unusual volume in today's session - ChartMill
Jingyan Wu Net Worth (2026) - GuruFocus
Shu Liu Net Worth (2026) - GuruFocus
Chenyu Andy Liang Net Worth (2026) - GuruFocus
Zifeng Wang Net Worth (2026) - GuruFocus
Mike Yao Zhou Net Worth (2026) - GuruFocus
Cellyan Biotechnology granted Nasdaq compliance extension; shares surge - MSN
Cellyan Biotechnology stock sinks 21% after hours: Here's what happened - MSN
Cellyan Biotechnology granted Nasdaq compliance extension; shares surge - MSN
What's going on in today's pre-market session - ChartMill
12 Industrials Stocks Moving In Friday's Pre-Market Session - Benzinga
Cellyan Biotechnology Wins Second Nasdaq Grace Period to Fix Sub-$1 Share Price - TipRanks
Cellyan Biotechnology stock sinks 21% after hours: Here's what happened - MSN
Cellyan Biotechnology Stock Sinks 21% After Hours: Here's What Happened - Benzinga
Cellyan Biotechnology Gets 180-Day Nasdaq Grace Period on Bid-Price Rule - marketscreener.com
Cellyan Biotechnology gets 180-day extension for Nasdaq compliance By Investing.com - Investing.com Nigeria
12 Industrials Stocks Moving In Thursday's After-Market Session - Benzinga
Cellyan Biotechnology granted Nasdaq compliance extension; shares surge - MSN
Thursday's after hours session: top gainers and losers - ChartMill
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period - The Manila Times
Cellyan Biotechnology gets 180-day extension for Nasdaq compliance - Investing.com
Cellyan Biotechnology Receives Nasdaq Extension to Regain Minimum Bid Price Compliance | HKPD Stock News - Quiver Quantitative
Nasdaq grants Cellyan Biotechnology (Nasdaq: HKPD) bid-price extension - Stock Titan
Ohmyhome Ltd Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency - Yahoo Finance
Cellyan Biotechnology Must Reach $1 Bid Price by Jan. 11 - Stock Titan
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period - Yahoo Finance
Cellyan Biotech (HKPD) Holds Steady Near Support After Minor DeclineMA Cross Alert - dars.gov.et
12 Industrials Stocks Moving In Wednesday's Intraday Session - Benzinga
12 Industrials Stocks Moving In Thursday's After-Market Session - Benzinga
12 Industrials Stocks Moving In Tuesday's Pre-Market Session - Benzinga
[EFFECT] Cellyan Biotechnology Co., Ltd SEC Filing - Stock Titan
Cellyan Biotechnology (HKPD) Slides 3.78% to $0.40 as Biotech Volatility PersistsBox Spread - dars.gov.et
Cellyan Biotech (HKPD) Slides 7.6%, Testing Key Support at $0.39Channel Projection - newsline.com
Cellyan Biotech (HKPD) Slides 7.6%, Testing Key Support at $0.39New Listing Stocks - newsline.com
Cellyan Biotechnology Co Ltd Stock (HKPD) Financials Data
There is no financial data for Cellyan Biotechnology Co Ltd (HKPD). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
7.72%
1.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):